Skip to Main Content


Katz Laboratory Seeks PhD Applicants for Postdoctoral Position

June 02, 2022

The Katz Laboratory in the Department of Pathology at Yale School of Medicine seeks applicants for an open Postdoctoral position. Accomplished PhD graduates seeking postdoctoral fellowship training in programmed cell death are invited to apply to Samuel Katz, MD, PhD, Associate Professor of Pathology.

Cell death signaling pathways are critical to diseases of cellular excess such as cancer and diseases of cellular loss such as neurodegeneration. Recent work has focused on the understudied BCL-2 family member, BOK, and its role in the formation of mitochondrial associated membranes. BCL-2 family proteins are vital regulators of mitochondrial integrity and have been implicated in the development, maintenance and chemoresistance of many cancers. The Katz Laboratory employs a multidisciplinary approach to study select pro-apoptotic BCL-2 family proteins.

Big picture questions of interest include:

  • How cell death programs regulate immune-silent vs. immune-stimulatory programs
  • How multiple different forms of cell death cross-talk with each other
  • How cell death proteins balance their death-regulatory functions with “day-jobs” that maintain normal cellular homeostasis

Successful candidates will be trained to develop an independent research career under the mentorship of Dr. Katz. Motivated candidates with strong written and verbal skills and expertise in biochemistry, molecular and cellular biology, live cell imaging, and/or flow cytometry are preferred. Interested candidates should forward a cover letter with your qualifications and research interests, curriculum vitae, and the names and addresses of three references via e-mail to Dr. Katz.

Yale is an affirmative action/equal opportunity employer. Yale values diversity among its students, faculty and staff and welcomes applications from women, members of minority groups, persons with disabilities, and protected veterans.

Submitted by Terence P. Corcoran on June 02, 2022